Mettler-Toledo Stock Price, News & Analysis

Mettler-Toledo International (NYSE:MTD) will present at the 41st Annual JP Morgan Healthcare Conference on January 10, 2023, at 12:00 p.m. ET. Interested investors can access the live webcast on the company’s investor relations page. A replay will be available for seven days. Mettler-Toledo is a global leader in precision instruments, holding strong market positions across various industries, including life sciences and food. The company is recognized for its innovation and extensive sales network, selling products in over 140 countries and having a direct presence in around 40.

Mettler-Toledo International Inc. (NYSE:MTD) announced that Olivier Filliol will not seek re-election to the Board of Directors in May 2023. Filliol, who served as President and CEO from 2008 to 2021 and joined the Board in 2009, played a crucial role in the CEO transition to Patrick Kaltenbach. Board Chair Robert F. Spoerry expressed gratitude for Filliol's invaluable contributions, emphasizing his dedication over 25 years. Mettler-Toledo is recognized as a global leader in precision instruments, with strong market positions and a commitment to innovation in various industries.

Mettler-Toledo International Inc. (NYSE:MTD) will present at the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, at 11:20 a.m. ET. The presentation will be available via live webcast on the company's investor relations page, with a replay accessible for seven days. Mettler-Toledo is a global leader in precision instruments, serving key industries like life sciences, food, and chemicals. The company holds strong market positions and has a robust sales and service network in over 140 countries, highlighting its commitment to innovation and financial growth.

Mettler-Toledo International (NYSE:MTD) announced the appointment of Ingrid Zhang to its Board of Directors, effective February 1, 2023. Zhang currently serves as President of China, Innovative Medicines at Novartis and has held various leadership roles in multinational pharmaceutical companies. Wah-Hui Chu will retire from the Board in May 2023 due to reaching the mandatory retirement age. Chair Robert F. Spoerry emphasized Zhang's extensive experience in the pharmaceutical industry and strategic insights for the dynamic Chinese market, while thanking Chu for his 16 years of service to the company.

Mettler-Toledo International reported a 4% increase in sales for Q3 2022, totaling $985.8 million. In local currency, sales grew 10%, with net earnings per share (EPS) rising to $9.76. Adjusted EPS reached $10.18, a 17% year-over-year increase. Regional performance varied: 11% growth in the Americas, 12% decline in Europe, and 7% growth in Asia. The company announced a new $2.5 billion share repurchase authorization while projecting 10% local currency sales growth and adjusted EPS of $38.95 to $39.05 for 2022.

Mettler-Toledo International announces an investor meeting in Boston on November 7, 2022. The event will feature a live webcast starting at 8:30 a.m. Eastern Time, accessible via www.mt.com/investors. A replay will be available for seven days post-event. Mettler-Toledo is a leading global supplier of precision instruments, holding top market positions in various sectors, including life sciences and manufacturing, with products sold in over 140 countries.

Mettler-Toledo International (NYSE:MTD) will hold a conference call on November 3, 2022, at 5:00 p.m. ET to discuss its quarterly results. Investors can access the live webcast at www.mt.com/investors, with a replay available until November 10, 2022. Mettler-Toledo is a leading global supplier of precision instruments, holding number-one market positions in various sectors. Their innovative solutions serve critical roles in R&D, quality control, and manufacturing across industries like life sciences, food, and chemicals. The company's extensive sales and service network spans over 140 countries.

Mettler-Toledo International Inc. (NYSE: MTD) has appointed Roland Diggelmann to its Board of Directors. Diggelmann previously served as CEO of Smith & Nephew Plc and Roche Diagnostics, bringing over 10 years of experience in the pharma/life sciences industry. His extensive international expertise and leadership in multinational companies are expected to provide valuable insights for Mettler-Toledo. The company is recognized as a leader in precision instruments across various industries, with a strong sales and service network worldwide.

Mettler-Toledo International Inc. (NYSE: MTD) reported a strong second quarter for 2022 with sales increasing by 6% year-over-year to $978.4 million. In local currency, sales grew 10%, driven by robust performance in the Americas (11% growth) and a 14% increase in Asia/Rest of World. Net earnings per diluted share rose to $9.29 from $7.85 in the prior year, with adjusted EPS up 16% to $9.39. Looking ahead, the company anticipates local currency sales growth of 9% to 10% for the year, with adjusted EPS guidance of $38.85 to $39.05.